Neuromodulation Platform Alleviates Chronic Pain
By HospiMedica International staff writers Posted on 26 May 2020 |
Image: The Senza Omnia SCS system (Photo courtesy of Nevro)
An innovative spinal cord stimulation system (SCS) treats chronic pain by delivering proprietary high frequency (HF) and other waveforms.
The Nevro (Menlo Park, CA, USA) Omnia system is a new SCS platform that offers a wide array of waveforms across the full SCS frequency spectrum, either separately or paired together with proprietary HF10. The system includes the Omnia programmer, a patient remote control that supports a programming capacity, allowing flexibility beyond the proprietary HF10 algorithm by providing the ability of employing additional waveforms. A third component is a redesigned, slimmer patient charger with an improved interface that is designed to last over ten years, no matter what stimulation profile is used.
An updated and upgradeable implantable pulse generator delivers an ultra-wide range of frequencies, between 2 and 10,000 Hz. In addition, the ability to pair frequencies allows Omnia to pair HF10--the most studied SCS therapy, with over 55,000 patients treated across the world--with other waveforms, including traditional, paresthesia-based stimulation, subthreshold 1 kHz therapy, or burst waveforms. In addition, the system has conditional full body magnetic resonance imaging (MRI) approval, and will be upgradeable to future waveforms and frequencies.
“This next-generation SCS system has been developed in close consultation with customers and is designed to provide a comprehensive solution to manage chronic pain. As conditions in the marketplace allow, we will be introducing Omnia to physicians throughout Europe,” said D. Keith Grossman, Chairman, CEO, and President of Nevro. “Omnia's versatility means that patients now have access to a full range of SCS solutions and physicians can have the peace of mind that when they implant the system, they will have the capabilities needed to achieve the best possible outcomes for their patients.”
“Nevro pioneered the development of HF10 therapy, which has been highly effective in managing chronic pain in my practice, and the new Omnia system provides an even more advanced platform,” said Werner Braunsdorf, MD, Chief Physician of the Clinic for Neurosurgery and Spine Surgery at the Magdeburg Hospital (Germany). “HF10 therapy has proven to be very effective in many studies as well as in clinical practice, but I believe there have been some instances where it would have been beneficial to pair HF10 therapy with other waveforms or offer different waveforms independently. Omnia now provides me with that unmatched versatility.”
Related Links:
Nevro
The Nevro (Menlo Park, CA, USA) Omnia system is a new SCS platform that offers a wide array of waveforms across the full SCS frequency spectrum, either separately or paired together with proprietary HF10. The system includes the Omnia programmer, a patient remote control that supports a programming capacity, allowing flexibility beyond the proprietary HF10 algorithm by providing the ability of employing additional waveforms. A third component is a redesigned, slimmer patient charger with an improved interface that is designed to last over ten years, no matter what stimulation profile is used.
An updated and upgradeable implantable pulse generator delivers an ultra-wide range of frequencies, between 2 and 10,000 Hz. In addition, the ability to pair frequencies allows Omnia to pair HF10--the most studied SCS therapy, with over 55,000 patients treated across the world--with other waveforms, including traditional, paresthesia-based stimulation, subthreshold 1 kHz therapy, or burst waveforms. In addition, the system has conditional full body magnetic resonance imaging (MRI) approval, and will be upgradeable to future waveforms and frequencies.
“This next-generation SCS system has been developed in close consultation with customers and is designed to provide a comprehensive solution to manage chronic pain. As conditions in the marketplace allow, we will be introducing Omnia to physicians throughout Europe,” said D. Keith Grossman, Chairman, CEO, and President of Nevro. “Omnia's versatility means that patients now have access to a full range of SCS solutions and physicians can have the peace of mind that when they implant the system, they will have the capabilities needed to achieve the best possible outcomes for their patients.”
“Nevro pioneered the development of HF10 therapy, which has been highly effective in managing chronic pain in my practice, and the new Omnia system provides an even more advanced platform,” said Werner Braunsdorf, MD, Chief Physician of the Clinic for Neurosurgery and Spine Surgery at the Magdeburg Hospital (Germany). “HF10 therapy has proven to be very effective in many studies as well as in clinical practice, but I believe there have been some instances where it would have been beneficial to pair HF10 therapy with other waveforms or offer different waveforms independently. Omnia now provides me with that unmatched versatility.”
Related Links:
Nevro
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery